Prenetics director acquires 2,000 shares via RSUs
Prenetics Global Ltd (PRE) reported that director Hudson Blake Leogrande exercised vested Restricted Stock Units (RSUs) on September 4, 2026.
Rhea-AI Filing Summary
Prenetics Global Ltd (PRE) reported that director Hudson Blake Leogrande exercised vested Restricted Stock Units (RSUs) on September 4, 2026. A total of 2,000 RSUs were settled into 2,000 Class A Ordinary Shares at a conversion price of $0.0000 per share under the 2022 Share Incentive Plan. Following the transaction, he held 6,001 Class A Ordinary Shares directly and 18,003 RSUs remained outstanding, each RSU representing a contingent right to one Class A Ordinary Share. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F2 | 2,000 | $0.00 | $0.00 |
| Exercise | Class A Ordinary Share, par value $0.0015 per share F1 | 2,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. 1. Represents 2,000 Class A Ordinary Shares of the Issuer issued and delivered upon settlement of vested Restricted Stock Units ("RSUs") granted under the Issuer's 2022 Share Incentive Plan.
- F2. Each RSU, granted under the Issuer's 2022 Share Incentive Plan, represents a contingent right to receive one Class A Ordinary Share. The 2,000 RSUs vested on June 4, 2026.
Key Figures
Key Terms
Restricted Stock Unit financial
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Prenetics Global Ltd (PRE) report in this Form 4?
What happened to the Prenetics (PRE) Restricted Stock Units in this Form 4 filing?
Were the Prenetics (PRE) RSUs exercised under a Rule 10b5-1 trading plan?
When did the Prenetics (PRE) RSUs involved in this Form 4 vest?
Under which plan were the Prenetics (PRE) RSUs granted to the director?
AI-generated analysis. How Rhea-AI works. Not financial advice.